Skip to main content
Equibles

ORBIMED ADVISORS LLC

Position in QURE — uniQure N.V.

CIK 1055951 New York, NY
Back to QURE Full portfolio

Position in QURE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$83,252,805
+$48,326,769 QoQ
Shares Held
1,807,486
-15.4% QoQ
Ownership
2.87%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#7
of 255 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 27% Shared 0% None 73%

Common Shares in QURE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. QURE ranks #9 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EWTX
Edgewise Therapeutics, Inc.
 15,518,492 $630,516,329
2 ELVN
Enliven Therapeutics, Inc.
 6,776,632 $343,914,074
3 MBX
MBX Biosciences, Inc.
 3,428,736 $189,266,227
4 GPCR
Structure Therapeutics Inc.
 2,209,400 $118,578,498
5 SION
Sionna Therapeutics, Inc.
 2,555,877 $112,433,029
6 CRVS
Corvus Pharmaceuticals, Inc.
 7,165,006 $107,045,189
7 AVBP
ArriVent BioPharma, Inc.
 3,027,328 $105,169,374
8 ARGX
Argenx SE
 92,880 $86,171,277

All Filings in QURE

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $83,252,805 1,807,486
2026-03-31 $34,926,036 2,136,149
2025-12-31 $17,645,982 737,400
2025-09-30 $26,762,645 458,500
2023-12-31 $9,125,283 1,347,900
2023-09-30 $13,852,493 2,064,455
2023-06-30 $23,658,654 2,064,455
2023-03-31 $41,578,123 2,064,455
2022-12-31 $39,617,071 1,747,555
2022-09-30 $29,959,720 1,597,000
2022-06-30 $16,307,185 874,849
2022-03-31 $16,610,829 919,249
2021-12-31 $12,144,804 585,574
2021-09-30 $18,744,223 585,574
2021-06-30 $14,512,159 471,174
2021-03-31 $32,648,271 969,079
2020-12-31 $35,012,824 969,079
2020-09-30 $35,691,179 969,079
2020-06-30 $43,666,699 969,079
2020-03-31 $46,689,803 983,979